AQR Capital Management
ETNB

AQR Capital Management’s 89bio ETNB Stock Holding History

AQR Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-88,325
Closed -$1.3M – 3591
2025
Q3 		$1.3M Buy
88,325
+8,793
+11% +$89.6K ﹤0.01% 2271
2025
Q2 		$781K Sell
79,532
-667
-0.8% -$5.52K ﹤0.01% 2345
2025
Q1 		$583K Buy
+80,199
New +$701K ﹤0.01% 2338
2023
Q4 		– Sell
-18,624
Closed -$288K – 2364
2023
Q3 		$288K Sell
18,624
-3,447
-16% -$57.9K ﹤0.01% 2021
2023
Q2 		$418K Buy
+22,071
New +$388K ﹤0.01% 1837

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AQR Capital Management's ETNB Position: Q4 2025 in Review

AQR Capital Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 88,325 shares — an estimated $1.3M sold.

AQR Capital Management first reported a position in ETNB in Q2 2023 and held it in 5 quarters. The position peaked at $1.3M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • AQR Capital Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • AQR Capital Management sold 88,325 89bio shares in Q4 2025, an estimated $1.3M.
  • AQR Capital Management first reported a position in 89bio in Q2 2023 and held it in 5 quarters.
  • AQR Capital Management's 89bio position peaked at $1.3M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.